Real-life Analysis Evaluating Treatments and Outcomes in Clalit Breast Cancer Patients for whom Adjuvant Treatment Decisions Incorporated the 21-gene Recurrence Score Results (Median Follow-up >5 Years)

Salomon M. Stemmer, M.D.

Head, Research Unit, Institute of Oncology, Davidoff Center, Rabin Medical Center. Affiliated to the Sackler Faculty of Medicine.